PDS Biotechnology Files 8-K
Ticker: PDSB · Form: 8-K · Filed: Jun 25, 2025 · CIK: 1472091
| Field | Detail |
|---|---|
| Company | Pds Biotechnology Corp (PDSB) |
| Form Type | 8-K |
| Filed Date | Jun 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, reporting, corporate-filing
TL;DR
PDS Biotech filed a standard 8-K on 6/25/25. No major news.
AI Summary
PDS Biotechnology Corporation filed an 8-K on June 25, 2025, reporting other events and financial statements. The company, formerly known as Edge Therapeutics, Inc., is incorporated in Delaware and headquartered in Princeton, NJ. This filing does not appear to contain specific material events or financial details beyond the standard reporting requirements.
Why It Matters
This 8-K filing indicates routine corporate reporting by PDS Biotechnology, without disclosing specific new material events or financial performance details.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not contain information that suggests an immediate change in risk for the company.
Key Players & Entities
- PDS Biotechnology Corporation (company) — Registrant
- Edge Therapeutics, Inc. (company) — Former Company Name
- June 25, 2025 (date) — Date of Report
- Princeton, NJ (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for PDS Biotechnology Corporation?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of June 25, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing is dated June 25, 2025.
What was PDS Biotechnology Corporation's former company name?
PDS Biotechnology Corporation's former company name was Edge Therapeutics, Inc.
Where are PDS Biotechnology Corporation's principal executive offices located?
PDS Biotechnology Corporation's principal executive offices are located at 303A College Road East, Princeton, NJ 08540.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 25, 2025 regarding PDS Biotechnology Corp (PDSB).